Welcome to the 5th Bacteriophage Therapy Summit:
The Global Industry Forum
Maturing Drug Development Expertise & Investment in Phage-Based Therapies to Better Understand In-Human Stability & Advance Clinical Benefit
From A-Z of phage development, the 5th Bacteriophage Therapy Summit is the definitive commercial-orientated conference to accelerate phage-based applications for organizations pioneering with phage pipelines.
Explore significant advancements in clinical trial design to push medicinal phage therapies to the clinic, CRISPR-based gene editing to improve functionality, the rise of lytic technologies, and alternative potential for phage technologies beyond human health. This is the conference of the year for biopharma, clinicians and consumer product developers to harness the safety and efficacy of phages.
Whether you’re at the forefront of the field or emerging into phage therapy for the first time, the 5th Bacteriophage Therapy Summit is the key networking platform that enables you to meaningfully apply phage science and prove commercial success.
2023 Speaker Faculty Includes:
Jakob Krause Haaber
Vice President, CRISPR & Delivery Technologies
Research Resources Section & Program Officer
National Institute of Health Science
US Food & Drug Administration (FDA)
Chief Legal Officer
Adaptive Phage Therapeutics Inc.
Chief Executive Officer, Co-Founder